Zhongjiang Shanghai Pudong Branch participated in the 9th World Pharmaceutical Raw Materials China Exhibition

　　Recently, CPHI (9th World Pharmaceutical Raw Materials China Exhibition) was held at the Shanghai New Century Expo Center. Ding Jisu, deputy manager of Zhongjiang Shanghai Pudong Branch, led all salesmen from the medical and chemical department to visit the Shanghai exhibition site, and conducted a systematic analysis of this year's pharmaceutical raw materials market based on the company's actual situation. Since the second half of last year, with the spread of the financial crisis, external demand has shrunk significantly. Various manufacturers in the pharmaceutical raw materials industry have carried out destocking sales to varying degrees, and have unanimously reduced this year's overall output to varying degrees. However, with the increase in foreign orders for colistin sulfate and other products from February to May, supplies have become tight and prices have been rising, while demand for amoxicillin and other products has been sluggish and low prices have been hovering. In response to this situation, the company's leaders formulated corresponding negotiation methods and negotiated with the manufacturers, which achieved good results and increased transaction opportunities. With the country's emphasis on environmental protection and the rising cost of human resources, the cost advantage of the pharmaceutical raw materials industry of southern China enterprises is gradually shrinking, and the output of products with high energy consumption, high pollution, and low technology content is gradually shrinking. We must spend more energy on the development of high-tech, new products and sub-new products to increase the added value of products and services.